Cantharidin

Drug identity has not yet been verified against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris)NCT07457918VRCAPhase 3Recruiting2027-11Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.